AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Agena Bioscience at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Agena Bioscience brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 629. Its program centres on pharmacogenomics implementation, with sessions on applying CPIC guidelines to NAT2 using CDC reference materials and on moving DPYD testing from guideline into routine practice.
| Organization | AMP 2026 Attendance |
|---|---|
Agena Bioscience San Diego, CA | |
MassARRAY platform for targeted genomic analysis — mutation profiling, liquid biopsy and pharmacogenetics for research laboratories. | Booth Exhibiting at Booth 629 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am NAT2 Pharmacogenomics: Applying CPIC Guidelines with CDC GeT-RM Reference Materials NAT2 acetylator genotyping: applying dosing guidelines and using CDC reference materials to validate the assay. Workshop Wed, Nov 11 12:00pm–12:50pm DPYD - From Guidelines to Implementation Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers. |
Find decision makers at Agena Bioscience
Tell us what you sell and we’ll find the people at Agena Bioscience most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction